Lisa Day v. HHS - Tdap, Guillain-Barre Syndrome (2021)
Case summary [AI summaries can sometimes make mistakes]
Lisa Day filed a petition for compensation under the National Vaccine Injury Compensation Program on July 9, 2019, alleging she suffered from Guillain-Barre Syndrome (GBS) after receiving a Tetanus-Diphtheria-acellular Pertussis (TDaP) vaccine on May 17, 2018. The respondent denied that the immunization caused her injury.
The parties, represented by Danielle Strait, Esq., for the petitioner and Claudia Gangi, Esq., for the respondent, reached a settlement agreement. The respondent agreed to pay Lisa Day a lump sum of $120,000.00 as compensation for all damages available under the program.
Special Master Mindy Michaels Roth adopted the parties' stipulation and awarded the compensation. The decision was issued on July 6, 2021.
The public decision does not describe the onset of symptoms, specific clinical details, medical tests, treatments, or expert witnesses.
Theory of causation
Petitioner Lisa Day alleged Guillain-Barre Syndrome (GBS) following a TDaP vaccination on May 17, 2018. Respondent denied causation. The parties stipulated to a settlement. The Special Master adopted the stipulation, awarding $120,000.00. The public decision does not detail the specific theory of causation, medical experts, or the mechanism of injury.
Source PDFs
USCOURTS-cofc-1_19-vv-00980